Clinical Trial Results:
A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the effects of aliskiren on proteinuria when added to standardized losartan therapy and optimal antihypertensive therapy in patients with hypertension and Type 2 diabetes mellitus
Summary
|
|
EudraCT number |
2004-000895-16 |
Trial protocol |
IE SK DK ES GB IT |
Global completion date |
04 Apr 2007
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
01 Jan 2017
|
First version publication date |
01 Jan 2017
|
Other versions |
|
Summary report(s) |
CSPP100C2201 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.